Evaluating behavioral, biochemical and histopathological effects of the MgO nanoparticles administration on memory in the Alzheimer-like model of male rat

Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 273

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_NAMJ-8-2_007

تاریخ نمایه سازی: 6 اردیبهشت 1400

Abstract:

Objective(s): This study has investigated the effects of acute and chronic administration of MgO nanoparticles (NP), on the memory, serum magnesium ions level, total antioxidant capacity and histopathological changes of the rat hippocampus in the Alzheimer-like model induced by streptozotocin (STZ). Materials and Methods: Adult male Wistar rats divided into: control, sham (STZ+ saline) and MgO NP ۱ and ۵ mg/kg groups. To induce Alzheimer’s disease, all rats except control group, received STZ (۳ mg/kg/ ۵ µl of saline) into the lateral ventricles during anesthesia. One week after surgery, passive avoidance learning was started by shuttle box device and saline or MgO NP acutely and chronically was administered after training. Memory tests were done at ۹۰ minutes and ۲۴ hours after training and one week after chronic administration. Immediately after the memory test, serum magnesium levels and total antioxidant capacity were measured, also the brain hippocampus tissue was removed for histopathological evaluation. STZ significantly impairs memory up to a week after the training. Results: Acute and chronic administration of MgO NP significantly improved short and long-term memory in the Alzheimer’s rats. Serum magnesium level decreased in the Alzheimer’s rats and MgO NP increased it in a dose-dependent manner. MgO NP ۱ mg/kg significantly increased serum total antioxidant capacity. MgO NP improved STZ-induced cell lesions in different parts of the hippocampus. Conclusions: It seems that MgO NP have the potential to improve brain lesions that have led to loss of memory and can be considered as an important component candidate for Alzheimer’s disease.

Authors

Mahnaz Kesmati

Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran

Norollah Tamoradi

Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran

Anahita Rezaie

Department of Pathobiology, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran

Ali Shahriyari

Department of Biochemistry, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran

Mozhgan Torabi

Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • 1.Xia X, Jiang Q, McDermott J, J Han J. Aging ...
  • 2.Crews L, Masliah E. Molecular mechanisms of neurodegeneration in Alzheimer’s ...
  • 3.Grigorenko A.P, Rogaev E.I. Molecular basis of Alzheimer’s disease. Molecular ...
  • 4.Jahn H.Memory loss in Alzheimer’s disease.Dialogues Clin Neurosci. 2013; 15(4): ...
  • 5.Zhu H, Yan H, Tang N, Li X, Pang P, ...
  • 6.Mancuso C, Bates T, Butterfield DA, Calafato S, Cornelius C, ...
  • 7.Setti SE, Hunsberger HC, Reed MN. Alterations in Hippocampal Activity ...
  • 8.Barbagallo M, Belvedere M, Sprini D, Dominguez L. Magnesium and ...
  • 9. Li W, Yu J, Liu Y, Huang X, Abumaria ...
  • 10.Sengupta J, Ghosh S, Datta P, Gomes A, Gomes A. ...
  • 11.Laffon B, Fernandez-Bertolez N, Costa C, Brandao F, Teixeira JP, ...
  • 12.Torabi M, Kesmati M, Pourreza N, Najafzadeh Varzi H, Galehdari ...
  • 13.Sargholi- nootarki Z, Kesmati M, Poormehdi Borujeni M. Effect of ...
  • 14.Kesmati M, Sargholi Notarki Z, Issapareh N, Torabi M. Comparison ...
  • 15.Torabi M, Kesmati M, Pourreza N, Najafzadeh Varzi H, Galehdari ...
  • 16.Javed H, Khan M, Ahmad A, Vaibhav K, Ahmad ME, ...
  • 17.Kamat PK. Streptozotocin induced Alzheimer’s disease like changes and the ...
  • 18.Nabaee E, Kesmati M, Shahriari A, Khajehpour L, Torabi M. ...
  • 19.Pohanka M, Bandouchova H, Sobotka J, Sedlackova J, Soukupova I, ...
  • 20.Agrawal R, Tyagi E, Shukla R, Nath C. A Study ...
  • 21.Salkovic-Petrisic M, Knezovic A, Hoyer S, Riederer P. What have ...
  • 22.Saxena G, Patro IK, Nath C. ICV STZ induced impairment ...
  • 23.Stranahan AM, Arumugam TV, Roy G, Cutler RG, Lee K, ...
  • 24.Suzanne M, Wands JR. Review of insulin and insulin-like growthfactor ...
  • 25.Sonkusare S, Srinivasan K, Kaul C, Ramarao P. Effect of ...
  • 26.Vural H, Demirin H, Kara Y, Delibas NE. Alterations of ...
  • 27. Keenoy BM, Moorkens G, Vertommen J, Noe M, Nève ...
  • 28.Veronese N, Zurlo A, Solmi M, Luchini C, Trevisan C, ...
  • 29.Persson T, Popescu BO, Cedazo-Minguez A. Oxidative Stress in Alzheimer’s ...
  • 30.Chui D, Chen Z, Yu J, Zhang H, Wang W, ...
  • 31.Slutsky I, Abumaria N, Wu LJ, Huang C, Zhang L, ...
  • 32.Serita T, Miyahara M, Tanimizu T, Takahashi S, Oishi S, ...
  • نمایش کامل مراجع